Anshen Dingzhi Ling (ADL)
Specifically for Attention-deficit Hyperactivity Disorder (ADHD)
0 up • 0 down
Why it works for Attention-deficit Hyperactivity Disorder (ADHD):
An Shén Dìng Zhì Líng (commonly written An Shen Dingzhi Ling / ASDZL / ADL) is a traditional Chinese medicine (TCM) compound formula used in China to treat ADHD-like symptoms. Preclinical (animal) studies and small clinical observations report beneficial effects — likely through anti-inflammatory actions and modulation of dopamine systems — but high-quality large randomized controlled trials comparable to those for stimulants/atomoxetine are lacking. There are also important safety and quality concerns (notably constituents such as Acorus calamus that can contain β-asarone), so use should be guided by a qualified clinician and by current regulatory labels.
- Anti-inflammatory / neuroinflammation modulation. A 2021 open-access study in Frontiers in Pharmacology (SHR rat model of ADHD) found that ASDZL reduced hyperactivity/impulsivity and improved spatial memory while lowering pro-inflammatory cytokines (IL-1β, IL-6, TNF-α, MCP-1), increasing IL-10, and reducing activation of microglia/astrocytes in prefrontal cortex and hippocampus — suggesting an anti-neuroinflammatory mechanism. Frontiers
- Effects on catecholamine / dopamine systems. Multiple animal studies (cited in the Frontiers paper and separate Chinese experimental reports) show ASDZL or its components can alter dopamine synthesis/transport, dopamine receptors and the dopamine transporter (DAT) in brain regions relevant to ADHD (prefrontal cortex, striatum). These changes are proposed to improve attention and reduce hyperactivity in rodent models. Frontiers
- Herbal constituents with neuroactive properties. The decoction contains herbs (e.g., Scutellariae (baicalin), Polygalae, Uncaria, Acorus/shi chang pu, etc.) that in separate pharmacology studies have shown anti-inflammatory, antioxidant, or neuromodulatory effects which may contribute to the overall action. The Frontiers article lists the formula composition and references prior component studies. Frontiers
Summary: preclinical and mechanistic data support plausible biological effects (anti-inflammatory + modulation of dopaminergic pathways), which could explain clinical benefit — but this evidence is mostly from animal studies and small clinical series rather than large RCTs. Frontiers
How to use for Attention-deficit Hyperactivity Disorder (ADHD):
There are three kinds of “instructions” in the literature: (A) how researchers prepare/use ASDZL in studies, (B) historical/classical recipe forms, (C) modern proprietary product dosing (varies by product/manufacturer).
A. Preparation & dosing used in the main experimental study (Frontiers, SHR rats):
- The authors prepared an ASDZL water decoction from 12 herbs (table of ingredients given in the paper). They concentrated the decoction to a crude-herb concentration and administered 21.25 g crude herb/kg/day orally to rats for 4 weeks (animal dosing; not a human dose). The methods section gives the exact extraction and concentration procedure. This is useful if you’re reading the pharmacology literature but do not apply the animal dose to humans directly. Frontiers
B. Traditional formula forms & example dosages (classical Anshen Dingzhi Wan / Anshen Dingzhi formulations):
- The classical formula “安神定志丸 / 安神定志丸” is documented in Chinese materia medica sources with component herbs and traditional pill preparations; example traditional dosing appears in classical sources (e.g., historical formula pages show typical pill doses such as 6 g per dose for certain formulations). Modern clinics however adapt composition and dose based on TCM diagnosis and age/weight. See a classical formula listing (Chinese). zysj.com.cn
C. Clinical practice / clinical trial dosing (human clinical reports):
- Clinical observational reports (e.g., Han & Zhu 2004 cited in the Frontiers review) and TCM clinical pathways in Jiangsu province describe using ASDZL clinically for pediatric ADHD; those clinical reports document benefit but are typically observational / small and sometimes use formula decoctions or granules with dosing adjusted for children. The Frontiers review cites the Han & Zhu (2004) clinical observation of 58 patients and other clinical reports; however the exact standardized modern human dosing is product-specific and not uniformly reported in English open literature. Frontiers
Practical note: If someone is considering ASDZL for a patient, an experienced TCM pediatrician or integrative physician should be consulted to:
- select an appropriate formulation (raw-herb decoction, standardized granule, or patent pill),
- calculate dose by age/weight and TCM pattern diagnosis,
- consider combination with or substitution for standard ADHD medication only under close supervision.
Scientific Evidence for Attention-deficit Hyperactivity Disorder (ADHD):
- Song Y. et al., 2021 — Frontiers in Pharmacology (open access)
- “An Shen Ding Zhi Ling Alleviates Symptoms of Attention Deficit Hyperactivity Disorder via Anti-Inflammatory Effects in Spontaneous Hypertensive Rats.” — detailed animal study showing behavioral improvement in SHR rats and biochemical/molecular anti-inflammatory effects. (Open access PDF & full text). Frontiers
- Chinese experimental studies (dopamine / DAT / receptor work) — several Chinese journal papers report that ADL alters DAT expression, dopamine receptors, synaptosomal DA synthesis/transport and related signaling pathways in SHR rats (examples summarized/cited within the Frontiers paper; examples: Lei et al. 2015; Zhou et al. 2017/2018; Liu et al. 2011). These are animal/mechanistic studies supporting the dopamine-related actions. Frontiers
- Clinical observation / small clinical trials (Chinese literature):
- Han X. & Zhu X. (2004). Clinical observation on 58 cases of ADHD treated with An Shen Ding Zhi Ling. (Hebei Journal of Traditional Chinese Medicine). This is frequently cited in later reviews but is an observational series (n≈58). The Frontiers paper cites it. Frontiers
- Several later Chinese clinical reports and small trials (and combination studies with atomoxetine) are summarized in TCM review articles; these generally report positive outcomes but are typically small or non-blinded. See reviews of TCM in ADHD. Frontiers
- Reviews of TCM approaches to ADHD: several narrative/systematic reviews of TCM for ADHD summarize clinical evidence across formulas (not only ASDZL). These reviews note some promising small trials but call for higher-quality RCTs. Example review sources: Traditional Chinese medicine in the treatment of ADHD (review articles and PDFs). ResearchGate
- Context from mainstream ADHD evidence reviews: large meta-analyses and reviews (Lancet Psychiatry, BMJ summaries) conclude that stimulants and atomoxetine have the strongest high-quality evidence for ADHD in adults and children; complementary medicines (including many TCM formulations) do not yet have the same level of high-quality randomized evidence. This is important context when weighing ASDZL evidence. The Lancet
Summary: animal mechanistic evidence is relatively strong and consistent; human clinical evidence consists of observational studies and small trials (mostly reported in Chinese journals) but larger, high-quality randomized, double-blind trials comparing ASDZL to standard treatments or placebo are limited. That makes ASDZL a promising but not yet definitively proven therapy by Western evidence-standards.
Specific Warnings for Attention-deficit Hyperactivity Disorder (ADHD):
Herb-specific toxicity — Acorus calamus (shi chang pu) and β-asarone:
- Acorus calamus (one ingredient in many ASDZL variants) can contain β-asarone, a compound that has shown carcinogenicity and other toxicities in animal studies. European/MHRA/EMA/WHO documents and toxicology studies discuss limits and concerns about β-asarone content; many regulators have restricted internal use of high-β-asarone calamus oil. If a modern product contains Acorus extract, its β-asarone content and source genotype matter for safety. European Medicines Agency (EMA)
Regulatory attention to “calming/brain-tonic” patent TCM products (China NMPA updates):
- China’s National Medical Products Administration (NMPA) has required unified revision of labels (adverse reactions, contraindications, interactions) for “安神补脑” (calm/spirit/brain-tonic) products — highlighting the need for careful attention to adverse events and drug interactions. This is a sign regulators are tightening safety information. Jiemian News
Possible allergic reactions and general herbal adverse effects: as with most multi-herb formulas, allergic reactions, GI upset, dizziness, or other idiosyncratic effects can occur. Individual product inserts / package leaflets should be read and adhered to. (General adverse-reaction summaries for related “an-shen” products are available from Chinese drug information sites.) ypk.39.net
Drug interactions (theoretical & reported): herbs that influence neurotransmitter systems (dopamine, noradrenaline, serotonin) could interact with ADHD medications (methylphenidate, atomoxetine), SSRIs, MAOIs, or other neuroactive drugs. Some Chinese clinical reports describe combination use (e.g., ASDZL + atomoxetine) — when combined, close monitoring by a qualified clinician is essential. The overall interaction profile is incompletely characterized in high-quality studies. ScienceDirect
Pregnancy, breastfeeding, children — extra caution: many patent herbal products carry contraindications or “use with caution” statements for pregnancy/infancy — and some ingredients (e.g., high β-asarone calamus) are specifically discouraged for internal use in many jurisdictions. Always check product label and consult a clinician. ypk.39.net
Quality control / standardization: multi-herb TCM preparations vary in composition, herb source, and possible contamination (heavy metals, pesticides, adulteration). Choose products from reputable manufacturers (and ideally those tested by independent quality labs) and obtain treatment from licensed practitioners. The clinical studies generally used authenticated herbs and standardized preparation; over-the-counter commercial products may not match study formulations. Frontiers
General Information (All Ailments)
What It Is
Nature / Type
- ADL is a TCM herbal prescription (a decoction or formula) used in Chinese medicine, especially in Jiangsu and affiliated hospitals, for the management of ADHD symptoms (inattention, hyperactivity, impulsivity) in children and in experimental models. Frontiers
- In the literature, the term often used is An Shen Ding Zhi Ling (ASDZL), which seems to be essentially the same or closely related to ADL in naming and function. Frontiers
Composition / Ingredients
- The formula is composed of multiple herbs — the version in a key animal-model study uses 12 herbs: Scutellariae Radix, Bupleuri Radix, Forsythiae Fructus, Curcumae Radix, Cassiae Semen, Bambusae Concretio Silicea, Uncariae Ramulus cum Uncis, Rehmanniae Radix, Acori Tatarinowii Rhizoma, Angelicae Sinensis Radix, Alpiniae Oxyphyllae Fructus, and Polygalae Radix. Frontiers
- Some earlier or variant studies also investigate how ADL acts on dopamine-related enzymes or receptors, indicating its “core formula” is modifiable or has multiple functional components. zgsyfjxzz.ijournals.cn
- One paper also mentions that ADL / Anshen Dingzhi Ling was formulated by Professor Xinmin Han and has been used clinically for over 20 years in certain TCM hospitals. Frontiers
Clinical / Empirical Use
- It is included in some Chinese Medical Clinical Pathway for treating ADHD protocols (in Jiangsu). Frontiers
- There are clinical observations (in China) of its use in children with ADHD; though rigorous randomized controlled trials (especially by Western standards) are more limited in availability in the public literature. Frontiers
How It Works (Proposed / Investigated Mechanisms)
Because TCM formulas are complex mixtures, the reported mechanisms are multiple and not fully settled. The studies mostly use animal models (especially spontaneously hypertensive rats, SHR) as models of ADHD. Below are main findings / hypotheses:
Reduction of Neuroinflammation
- ADL / ASDZL appears to reduce proinflammatory cytokines (IL-1β, IL-4, IL-6, TNF-α, MCP-1) and increase anti-inflammatory factors such as IL-10 in the prefrontal cortex and hippocampus in SHR models. Frontiers
- It also seems to reduce activation of glial and immune cells in the brain: microglia, astrocytes, and mast cells show reduced activation in treated animals. Frontiers
- The formula also is associated with protection of the blood-brain barrier (BBB) integrity, which is relevant because neuroinflammation often involves BBB disruption. Frontiers
- In terms of signaling, suppression of MAPK and NF-κB signaling pathways (common inflammatory pathways) has been observed in treated animals. Frontiers
Modulation of Dopaminergic / Dopamine System
- Because ADHD is often conceptualized (in part) as a disorder of dopamine signaling (insufficient dopamine in synapses, dysregulation of transporter or receptor function), ADL has been studied for its influence on these systems:
- In one study, ADL increased expression and activity of tyrosine hydroxylase (TH), dopa decarboxylase (DDC), and protein kinase A (PKA) in synaptosomes (i.e. in neurotransmitter release machinery), which are enzymes relevant to dopamine synthesis and signaling. This suggests ADL may increase the speed or capacity of dopamine synthesis. zgsyfjxzz.ijournals.cn
- Another study looked at dopamine transporter (DAT) expression: ADL (medium and high dose) reduced DAT mRNA and protein expression in striatum of SHR rats (DAT is the reuptake transporter which, when reduced, leads to more dopamine remaining in the synaptic cleft). Thus ADL may block reuptake of dopamine, allowing more dopamine in synapses. xueshu.baidu.com
- It also influences dopamine receptor expression. For example, a study measured DRD1 and DRD2 expression in prefrontal cortex and striatum in SHR rats with/without ADL treatment, showing that ADL may modulate those receptor levels. Peertechz Publications
- In a more recent mechanistic paper, the authors explored how ADL influences the BDNF / TrkB signaling pathway (brain-derived neurotrophic factor) in PFC and hippocampus synaptosomes. They found that ADL can increase levels of BDNF, TrkB, p75, JNK1, and NF-κB in synaptosome compartments. The authors propose that ADL mediates a balance between BDNF/TrkB (which promotes vesicle circulation / neurotransmitter release) and BDNF/p75/JNK1/NF-κB (which may inhibit vesicle circulation), thereby modulating dopamine release/availability in synaptic clefts. Semantic Scholar
- Through these mechanisms, ADL aims to increase the concentration of dopamine in the synaptic cleft, improve dopamine signaling / neurotransmission, and thereby mitigate ADHD-like behaviors. Semantic Scholar
Behavioral / Cognitive Effects in Animal Models
- In SHR animals, ADL treatment over weeks reduced hyperactivity and impulsivity, and improved spatial memory, as assessed by open field tests and Morris water maze tests, compared to untreated SHR controls. Frontiers
- The behavioral improvement is taken as a correlate to its biochemical effects above.
Why It’s Important / What It Offers
Alternative / Complementary to Existing ADHD Treatments
- Many conventional ADHD treatments (e.g. stimulants like methylphenidate, non-stimulants) have side effects, and not all patients respond well. A TCM adjunct or alternative like ADL may provide a complementary approach, especially in settings (China, TCM hospitals) where integration of herbal medicine with conventional medicine is practiced.
Multi-target and Multi-mechanism
- As an herbal formula with many components, ADL can act on multiple pathways (inflammation, dopamine synthesis, transport, receptor expression, neurotrophic factors). This “systems” or network effect is appealing in complex brain disorders where multiple dysregulated pathways coexist.
Focus on Neuroinflammation
- Emerging research suggests neuroinflammation plays a role in various psychiatric / neurodevelopmental conditions, including ADHD. ADL’s anti-inflammatory properties in the CNS may address aspects of ADHD pathophysiology not targeted by standard stimulant therapies. Frontiers
Regulation of Synaptic Dopamine Homeostasis
- By modulating the balance of dopamine synthesis, reuptake, receptor sensitivity, and synaptic release (via BDNF pathways), ADL has the potential to more finely “tune” dopaminergic signaling rather than bluntly pushing dopamine levels upward, which might reduce side effects.
Cultural / Clinical Relevance in Chinese Medicine Context
- In Chinese clinical practice, formula-based herbal medicine is integrated routinely. Having a formula like ADL that is recognized and used in TCM hospitals and clinical pathways lends it relevance where patients are already seeking combined (integrative) therapies.
Considerations, Limitations, & Cautions
While the research is promising, there are many caveats and limitations to keep in mind:
Evidence Level & Human Clinical Trials
- Much of the mechanistic and efficacy evidence comes from animal models (especially SHR rats). Translating these findings to humans is nontrivial. Frontiers
- The human clinical evidence is more limited. There are observational / “clinical observation” reports (in children) of ADHD symptom improvement, but few high-quality randomized, double-blind, placebo-controlled trials published (especially in English) to firmly establish efficacy and safety. Semantic Scholar
- The methodologies of existing human studies are often not well documented in public literature, making critical assessment challenging.
Formulation Consistency and Standardization
- Herbal formulas can vary in exact herb sources, quality, processing, dosages, extraction methods, etc. This introduces variability in potency, bioavailability, and safety.
- The translation of dosages from animal models (often very high per kg) to safe human-equivalent doses is nontrivial.
Complex Mixture and Potential Interactions
- Because ADL involves many herbs, it may interact (synergistically or antagonistically) with conventional medications (e.g. stimulants, antidepressants, antipsychotics, or other CNS-active drugs). These interactions are not well studied in the public literature.
- Herbal formulas may also have components that stress the liver, kidney, or other organs, or cause allergic or idiosyncratic reactions. Adequate toxicology profiling is essential before wide clinical use.
Safety, Toxicity, and Long-Term Effects
- Long-term safety (especially in children) is largely unknown in rigorous studies.
- Some herbal formulas, if misprepared or contaminated, may carry risks (heavy metals, adulteration, contamination). Quality control is crucial.
Regulatory and Ethical Issues
- In many countries, herbal formulas are regulated differently from pharmaceuticals. Their claims may not be tightly controlled, and oversight of manufacturing standards may vary.
- In clinical settings outside of China, integrating ADL would require navigating regulatory, institutional, and evidence-based medicine standards.
Patient Selection and TCM Diagnosis
- In TCM practice, formulas are often prescribed not solely on disease label but on pattern differentiation (i.e. the specific “syndrome” in the TCM framework). ADL may be more effective in patients whose TCM diagnosis matches a pattern for which ADL is indicated.
- Not every ADHD patient would “fit” the TCM pattern for which ADL is optimal; a one-size-fits-all use may reduce effectiveness or increase adverse effects.
Comparison to Conventional Therapies
- It remains uncertain how ADL compares with standard ADHD medications in terms of effect size, onset speed, side effect profile, and durability of benefits.
- Combining ADL with standard therapies might offer synergistic benefits but also could lead to unforeseen interactions.
Helps with these conditions
Anshen Dingzhi Ling (ADL) is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.
Detailed Information by Condition
Attention-deficit Hyperactivity Disorder (ADHD)
An Shén Dìng Zhì Líng (commonly written An Shen Dingzhi Ling / ASDZL / ADL) is a traditional Chinese medicine (TCM) compound formula used in China to...
Community Discussion
Share results, tips, and questions about Anshen Dingzhi Ling (ADL).
Loading discussion...
No comments yet. Be the first to start the conversation!
Discussion for Attention-deficit Hyperactivity Disorder (ADHD)
Talk specifically about using Anshen Dingzhi Ling (ADL) for Attention-deficit Hyperactivity Disorder (ADHD).
Loading discussion...
No comments yet. Be the first to start the conversation!
Remedy Statistics
Helps With These Conditions
Recommended Products
No recommended products added yet.